연구성과로 돌아가기
JCR 2023 저널 목록 (977 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CANCER CHEMOTHERAPY AND PHARMACOLOGY | SPRINGER | 0344-5704 | 1432-0843 | SCIE | ONCOLOGY | 9,563 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 2.7 | Q3 | 2.6 | 0.5 | 0.70 | 146/322 | Q2 | 54.81 | 0.006 | 1.237 | 0.704 | Q3 | 120 | 90.8% | 9.4 | 6.9 | 109 | 29.0% | 2025-03-24 17:33:42 | 바로가기 |
| Clinical and Translational Radiation Oncology | ELSEVIER IRELAND LTD | N/A | 2405-6308 | SCIE | ONCOLOGY | 1,801 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 3.3 | Q2 | 2.6 | 0.5 | 0.77 | 127/322 | Q2 | 60.71 | 0.004 | 0.857 | 0.962 | Q2 | 139 | 93.5% | 3.5 | 6.2 | 130 | 78.4% | 2025-03-24 17:33:57 | 바로가기 |
| Clinical Lymphoma Myeloma & Leukemia | CIG MEDIA GROUP, LP | 2152-2650 | 2152-2669 | SCIE | ONCOLOGY | 4,083 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 2.4 | Q3 | 2.6 | 0.6 | 0.48 | 216/322 | Q3 | 33.07 | 0.007 | 1.619 | 0.854 | Q2 | 134 | 69.4% | 4.3 | 5.6 | 93 | 17.9% | 2025-03-24 17:33:49 | 바로가기 |
| Colorectal Cancer | TAYLOR & FRANCIS LTD | 1758-194X | 1758-1958 | ESCI | ONCOLOGY | 118 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 2.4 | Q3 | 2.7 | 1.0 | 0.23 | 285/322 | Q4 | 11.65 | 0.000 | 0.037 | 0.759 | Q3 | 4 | 75.0% | 5.2 | 5.8 | 3 | 71.4% | 2025-03-24 17:34:09 | 바로가기 |
| CRIMINAL JUSTICE STUDIES | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 1478-601X | 1478-6028 | ESCI | OPERATIONS RESEARCH & MANAGEMENT SCIENCE | 488 | 1.9 | Q3 | 50.5 | 49.5 | 54/106 | 1.7 | Q3 | 1.8 | 0.1 | 0.54 | 55/106 | Q3 | 48.58 | 0.001 | 0.139 | 0.660 | Q2 | 24 | 100.0% | 7.7 | 9.3 | 24 | 4.7% | 2025-03-24 17:34:21 | 바로가기 |
| Current Hematologic Malignancy Reports | CURRENT MEDICINE GROUP | 1558-8211 | 1558-822X | SCIE | ONCOLOGY | 1,299 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 3.0 | Q3 | 2.6 | 0.6 | 0.41 | 236/322 | Q3 | 26.86 | 0.002 | 0.414 | 0.924 | Q2 | 34 | 0.0% | 5.4 | 5.3 | 0 | 8.5% | 2025-03-24 17:34:00 | 바로가기 |
| CUTIS | QUADRANT HEALTHCOM INC | 0011-4162 | 2326-6929 | SCIE | DERMATOLOGY | 2,051 | 2.1 | Q3 | 50.5 | 49.5 | 48/94 | 1.7 | Q3 | 2.0 | 0.7 | 0.36 | 73/94 | Q4 | 22.87 | 0.002 | 0.356 | 0.513 | Q3 | 38 | 65.8% | 9.7 | 8.1 | 25 | 1.3% | 2025-03-24 17:04:00 | 바로가기 |
| DEVELOPMENTAL PSYCHOBIOLOGY | WILEY | 0012-1630 | 1098-2302 | SCIE | PSYCHOLOGY | 4,458 | 1.9 | Q3 | 50.5 | 49.5 | 47/92 | 2.2 | Q3 | 1.8 | 0.6 | 0.66 | 45/92 | Q2 | 51.63 | 0.004 | 0.828 | 0.750 | Q2 | 83 | 88.0% | 10.4 | 10.3 | 73 | 15.3% | 2025-03-24 18:06:20 | 바로가기 |
| Diversity-Basel | MDPI | N/A | 1424-2818 | SCIE | ECOLOGY | 7,634 | 2.1 | Q3 | 50.5 | 49.5 | 100/197 | 2.3 | Q3 | 1.8 | 0.7 | 0.63 | 101/197 | Q3 | 48.98 | 0.011 | 2.333 | 0.493 | Q3 | 1194 | 93.8% | 2.6 | 11.7 | 1120 | 99.8% | 2025-03-24 17:04:23 | 바로가기 |
| Environmental Science-Atmospheres | ROYAL SOC CHEMISTRY | N/A | 2634-3606 | ESCI | METEOROLOGY & ATMOSPHERIC SCIENCES | 540 | 2.8 | Q3 | 50.5 | 49.5 | 56/110 | 2.8 | Q3 | 2.5 | 0.8 | 0.65 | 61/110 | Q3 | 45.00 | 0.001 | 0.252 | 0.830 | Q3 | 100 | 95.0% | 1.6 | 8.3 | 95 | 100.0% | 2025-03-24 17:30:42 | 바로가기 |
| European Journal of Industrial Engineering | INDERSCIENCE ENTERPRISES LTD | 1751-5254 | 1751-5262 | SCIE | OPERATIONS RESEARCH & MANAGEMENT SCIENCE | 555 | 1.9 | Q3 | 50.5 | 49.5 | 54/106 | 1.8 | Q3 | 1.7 | 0.4 | 0.33 | 85/106 | Q4 | 20.28 | 0.000 | 0.086 | 0.310 | Q4 | 31 | 100.0% | 5.8 | 7.7 | 31 | 0.0% | 2025-03-24 17:34:20 | 바로가기 |
| European Journal of Oncology Nursing | ELSEVIER SCI LTD | 1462-3889 | 1532-2122 | SCIE | ONCOLOGY | 3,809 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 3.0 | Q3 | 2.5 | 0.5 | 0.98 | 81/322 | Q2 | 75.00 | 0.003 | 0.769 | 0.770 | Q3 | 185 | 88.6% | 6.7 | 6.2 | 164 | 19.7% | 2025-03-24 17:33:50 | 바로가기 |
| IMA Journal of Management Mathematics | OXFORD UNIV PRESS | 1471-678X | 1471-6798 | SCIE | OPERATIONS RESEARCH & MANAGEMENT SCIENCE | 615 | 1.9 | Q3 | 50.5 | 49.5 | 54/106 | 1.8 | Q3 | 1.4 | 0.8 | 0.62 | 44/106 | Q2 | 58.96 | 0.000 | 0.104 | 0.391 | Q4 | 26 | 96.2% | 6.7 | 7.7 | 25 | 15.9% | 2025-03-24 17:34:19 | 바로가기 |
| Indian Journal of Psychological Medicine | SAGE PUBLICATIONS INC | 0253-7176 | 0975-1564 | ESCI | PSYCHOLOGY | 2,496 | 1.9 | Q3 | 50.5 | 49.5 | 47/92 | 2.6 | Q2 | 1.8 | 0.3 | 0.52 | 63/92 | Q3 | 32.07 | 0.003 | 0.613 | 0.673 | Q3 | 61 | 85.2% | 5.6 | 8.5 | 52 | 94.7% | 2025-03-24 18:06:21 | 바로가기 |
| JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | SPRINGER | 0171-5216 | 1432-1335 | SCIE | ONCOLOGY | 11,501 | 2.7 | Q3 | 50.5 | 49.5 | 163/322 | 3.1 | Q2 | 2.6 | 0.5 | 0.62 | 172/322 | Q3 | 46.74 | 0.012 | 2.602 | 0.765 | Q3 | 969 | 89.1% | 5.2 | 5.6 | 863 | 35.1% | 2025-03-24 17:33:41 | 바로가기 |
페이지 이동: